Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.

作者: Boris B. Quednow , Magdalena M. Brzózka , Moritz J. Rossner

DOI: 10.1007/S00018-013-1553-4

关键词:

摘要: Schizophrenia is a genetically complex disease considered to have neurodevelopmental pathogenesis and defined by broad spectrum of positive negative symptoms as well cognitive deficits. Recently, large genome-wide association studies identified common alleles slightly increasing the risk for schizophrenia. Among few schizophrenia-risk genes that been consistently replicated basic Helix-Loop-Helix (bHLH) transcription factor 4 (TCF4). Haploinsufficiency TCF4 (formatting follows IUPAC nomenclature: protein/protein function, Tcf4 rodent gene cDNA mRNA, human mRNA) causes Pitt-Hopkins syndrome-a characterized severe mental retardation. Accordingly, null-mutant mice display developmental brain defects. TCF4-associated are located in putative coding non-coding regions gene. Hence, subtle changes at level expression might be relevant etiopathology Behavioural phenotypes obtained with mouse model increased dosage electrophysiological investigations risk-allele carriers revealed an overlapping schizophrenia-relevant endophenotypes. Most prominently, early information processing higher functions appear associated genotypes. Moreover, recent study unravelled × environment interactions between smoking behaviour were specifically disrupted processing. Taken together, integrator ('hub') several bHLH networks controlling critical steps various developmental, and, possibly, plasticity-related transcriptional programs CNS also affect important Consequently, these findings support hypothesis schizophrenia provide basis identifying underlying molecular mechanisms.

参考文章(209)
Alessandro Guidotti, Christine Pesold, Erminio Costa, New Neurochemical Markers for Psychosis: A Working Hypothesis of Their Operation Neurochemical Research. ,vol. 25, pp. 1207- 1218 ,(2000) , 10.1023/A:1007635927069
William G Honer, Clint E Young, Presynaptic proteins and schizophrenia. International Review of Neurobiology. ,vol. 59, pp. 175- ,(2004) , 10.1016/S0074-7742(04)59007-4
Friston Kj, Frith Cd, Schizophrenia: a disconnection syndrome? Clinical Neuroscience. ,vol. 3, pp. 89- 97 ,(1995)
W Berrettini, X Yuan, F Tozzi, K Song, C Francks, H Chilcoat, D Waterworth, P Muglia, V Mooser, α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking Molecular Psychiatry. ,vol. 13, pp. 368- 373 ,(2008) , 10.1038/SJ.MP.4002154
Ingrid DC Van Balkom, Pieter Jelle Vuijk, Marijke Franssens, Hans W Hoek, Raoul CM Hennekam, None, Development, cognition, and behaviour in Pitt-Hopkins syndrome Developmental Medicine & Child Neurology. ,vol. 54, pp. 925- 931 ,(2012) , 10.1111/J.1469-8749.2012.04339.X
M. Ishibashi, K. Moriyoshi, Y. Sasai, K. Shiota, S. Nakanishi, R. Kageyama, Persistent expression of helix‐loop‐helix factor HES‐1 prevents mammalian neural differentiation in the central nervous system. The EMBO Journal. ,vol. 13, pp. 1799- 1805 ,(1994) , 10.1002/J.1460-2075.1994.TB06448.X
Yuki Nakamura, Shin-ichi Sakakibara, Takaki Miyata, Masaharu Ogawa, Takuya Shimazaki, Samuel Weiss, Ryoichiro Kageyama, Hideyuki Okano, The bHLH Gene Hes1 as a Repressor of the Neuronal Commitment of CNS Stem Cells The Journal of Neuroscience. ,vol. 20, pp. 283- 293 ,(2000) , 10.1523/JNEUROSCI.20-01-00283.2000
Wulf Rössler, Michael P. Hengartner, Jules Angst, Vladeta Ajdacic-Gross, Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years Addiction. ,vol. 107, pp. 1174- 1184 ,(2012) , 10.1111/J.1360-0443.2011.03760.X